People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

Saline nasal drops also help flush out mucous and inflammatory mediators, which can improve cold symptoms and give the immune ...

The researchers divided them into two groups: one group used hypertonic saline nasal drops, while the other group followed ... the saline used in the study wasn’t your regular saline spray. It was ...